谷歌浏览器插件
订阅小程序
在清言上使用

Using a Novel Measuring Device to Objectively Evaluate the Clinical Benefit on Ptosis in Infantile-Onset Pompe Disease (IOPD): Results from 145 Weeks' Avalglucosidase Alfa Dosing in Mini-COMET Participants Previously Treated with Alglucosidase Alfa

MOLECULAR GENETICS AND METABOLISM(2024)

引用 0|浏览6
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要